Mice fed a high-fat diet supplemented with resistant starch display marked shifts in the liver metabolome concurrent with altered gut bacteria

Journal of Nutrition

Volumn 146, Issue 12, 2016, Pages 2476-2490

  Kieffer, Dorothy A ^a,b   Piccolo, Brian D ^c,d   Marco, Maria L ^a   Kim, Eun Bae ^a,e   Goodson, Michael L ^a   Keenan, Michael J ^f   Dunn, Tamara N ^a,b   Knudsen, Knud Erik Bach ^g   Martin, Roy J ^a,b   Adams, Sean H ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e Kangwon National University   (South Korea)

^f LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

^g AARHUS UNIVERSITY   (Denmark)

Author keywords

Dietary fiber; Gut microbiota; Liver; Metabolomics; Transcriptomics

Indexed keywords

AMINO ACID TRANSPORTER; HIGH AMYLOSE MAIZE RESISTANT STARCH TYPE 2; STARCH; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FAT INTAKE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET RESTRICTION; DIETARY FIBER; FOOD INTAKE; GENE EXPRESSION; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INTESTINE FLORA; LIPID DIET; LIVER METABOLISM; MAIZE; MALE; MOUSE; NONHUMAN; PORTAL VEIN BLOOD FLOW; XENOBIOTIC METABOLISM; ADMINISTRATION AND DOSAGE; ANIMAL; BACTERIUM; C57BL MOUSE; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; FAT INTAKE; GASTROINTESTINAL TRACT; LIVER; METABOLISM; MICROBIOLOGY; OBESITY; RANDOMIZATION;

ADIPOSITY; ANIMALS; BACTERIA; DIETARY FATS; GASTROINTESTINAL TRACT; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; RANDOM ALLOCATION; STARCH;

EID: 84997300763     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.116.238931     Document Type: Article

References (67)

1. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009;15:1546-58.
2. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009;90:1236-43.
3. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulinsensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005;82:559-67.
4. Natarajan N, Pluznick JL. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. Am J Physiol Cell Physiol 2014;307:C979-85.
5. Zhang LS, Davies SS. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med 2016;8:46.
6. Annison G, Topping DL. Nutritional role of resistant starch: chemical structure vs physiological function. Annu Rev Nutr 1994;14:297-320.
7. Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 2010;5:e15046.
8. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 2008;295:E1160-6.
9. Haenen D, Zhang J, da Silva CS, Bosch G, van der Meer IM, van Arkel J, van den Borne JJ, Gutiérrez OP, Smidt H, Kemp B. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J Nutr 2013;143:274-83.
10. Polakof S, Díaz-Rubio ME, Dardevet D, Martin J-F, Pujos-Guillot E, Scalbert A, Sebedio J-L, Mazur A, Comte B. Resistant starch intake partly restores metabolic and inflammatory alterations in the liver of high-fat-diet-fed rats. J Nutr Biochem 2013;24:1920-30.
11. Wang Z, Zhang Y, Shi R, Zhou Z, Wang F, Strappe P. A novel gene network analysis in liver tissues of diabetic rats in response to resistant starch treatment. Springerplus 2015;4:110.
12. Thomas AP, Dunn TN, Drayton JB, Oort PJ, Adams SH. A high calcium diet containing nonfat dry milk reduces weight gain and associated adipose tissue inflammation in diet-induced obese mice when compared to high calcium alone. Nutr Metab 2012;9:3-11.
13. Tulley RT, Appel MJ, Enos TG, Hegsted M, McCutcheon KL, Zhou J, Raggio AM, Jeffcoat R, Birkett A, Martin RJ, et al. Comparative methodologies for measuring metabolizable energy of various types of resistant high amylose corn starch. J Agric Food Chem 2009;57:8474-9.
14. Kieffer DA, Piccolo BD, Marco ML, Kim EB, Goodson ML, Keenan MJ, Dunn TN, Knudsen KEB, Adams SH, Martin RJ. Obese mice fed a diet supplemented with enzyme-treated wheat bran display marked shifts in the liver metabolome concurrent with altered gut bacteria. J Nutr 2016;146:2445-60.
15. R Core Team. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2014.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995;57:289-300.
17. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB. Missing value estimation methods for DNA microarrays. Bioinformatics 2001;17:520-5.
18. Mehmood T, Liland KH, Snipen L, Sæbø S. A review of variable selection methods in partial least squares regression. Chemom Intell Lab Syst 2012;118:62-9.
19. Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom Intell Lab Syst 2001;58:109-30.
20. Canty A, Ripley B. Boot: Bootstrap R (S-Plus) functions. R package version 2.0.1 [Internet]. 2015 [cited 2015 Sep 15]. Available from: https://cran.r-project.org/package=boot.
21. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011;5(2):220-30. [cited 2015 Jul 25]. Available from: http://www. nature.com/ismej/journal/v5/n2/suppinfo/ismej2010118s1.html.
22. Wang X, Brown I, Khaled D, Mahoney M, Evans A, Conway P. Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amylomaize) starch granules. J Appl Microbiol 2002;93:390-7.
23. Tachon S, Zhou J, Keenan M, Martin R, Marco M. The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses. FEMS Microbiol Ecol 2013;83:299-309.
24. Keenan MJ, Martin RJ, Raggio AM, McCutcheon KL, Brown IL, Birkett A, Newman SS, Skaf J, Hegsted M, Tulley RT. High-amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study. J Nutrigenet Nutrigenomics 2012;5:26-44.
25. Haenen D, Souza da Silva C, Zhang J, Koopmans SJ, Bosch G, Vervoort J, Gerrits WJJ, Kemp B, Smidt H, Müller M, et al. Resistant starch induces catabolic but suppresses immune and cell division pathways and changes the microbiome in the proximal colon of male pigs. J Nutr 2013;143:1889-98.
26. Keenan MJ, Janes M, Robert J, Martin RJ, RaggioAM, McCutcheon KL, Pelkman C, Tulley R, Goita MF, Durham HA. Resistant starch from high amylose maize (HAM-RS2) reduces body fat and increases gut bacteria in ovariectomized (OVX) rats. Obesity (Silver Spring) 2013;21:981-4.
27. Keenan MJ, Zhou J, McCutcheon KL, Raggio AM, Bateman HG, Todd E, Jones CK, Tulley RT, Melton S, Martin RJ, et al. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 2006;14:1523-34.
28. Toden S, Bird AR, Topping DL, Conlon MA. High red meat diets induce greater numbers of colonic DNA double-strand breaks than white meat in rats: attenuation by high-amylose maize starch. Carcinogenesis 2007;28:2355-62.
29. Topping DL, Gooden JM, Brown IL, Biebrick DA, McGrath L, Trimble RP, Choct M, Illman RJ. A high amylose (amylomaize) starch raises proximal large bowel starch and increases colon length in pigs. J Nutr 1997;127:615-22.
30. Kleessen B, Stoof G, Proll J, Schmiedl D, Noack J, Blaut M. Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. J Anim Sci 1997;75:2453-62.
31. Charrier JA, Martin RJ, McCutcheon KL, Raggio AM, Goldsmith F, Goita MF, Senevirathne RN, Brown IL, Pelkman C, Zhou J. High fat diet partially attenuates fermentation responses in rats fed resistant starch from high-amylose maize. Obesity (Silver Spring) 2013;21:2350-5.
32. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003;62:67-72.
33. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014;20:159-66.
34. Holscher HD, Caporaso JG, Hooda S, Brulc JM, Fahey GC, Swanson KS. Fiber supplementation influences phylogenetic structure and functional capacity of the human intestinal microbiome: follow-up of a randomized controlled trial. Am J Clin Nutr 2015;101:55-64.
35. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.
36. Jeffery IB, O'Toole PW, Ohman L, Claesson MJ, Deane J, Quigley EM, Simren M. An irritable bowel syndrome subtype defined by speciesspecific alterations in faecal microbiota. Gut 2012;61:997-1006.
37. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sorensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from nondiabetic adults. PLoS One 2010;5:e9085.
38. Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuño MI. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med 2013;11:46.
39. Kashyap PC, Marcobal A, Ursell LK, Larauche M, Duboc H, Earle KA, Sonnenburg ED, Ferreyra JA, Higginbottom SK, Million M, et al. Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 2013;144:967-77.
40. Birt DF, Boylston T, Hendrich S, Jane J-L, Hollis J, Li L, McClelland J, Moore S, Phillips GJ, Rowling M, et al. Resistant starch: promise for improving human health. Adv Nutr 2013;4:587-601.
41. Flint HJ, Scott KP, Duncan SH, Louis P, Forano E.Microbial degradation of complex carbohydrates in the gut. Gut Microbes 2012;3:289-306.
42. Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 2012;6:1535-43.
43. Ze X, Ben David Y, Laverde-Gomez JA, Dassa B, Sheridan PO, Duncan SH, Louis P, Henrissat B, Juge N, Koropatkin NM, et al. Unique organization of extracellular amylases into amylosomes in the resistant starch-utilizing human colonic Firmicutes bacterium Ruminococcus bromii. MBio 2015;6:e01058-15.
44. Maathuis A, Hoffman A, Evans A, Sanders L, Venema K. The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine. J Am Coll Nutr 2009;28:657-66.
45. Gill H, Prasad J. Probiotics, immunomodulation, and health benefits. In: Bioactive components of milk. New York: Springer; 2008. p. 423-54.
46. Kalmokoff M, Zwicker B, O'Hara M, Matias F, Green J, Shastri P, Green-Johnson J, Brooks SPJ. Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate availability. J Appl Microbiol 2013;114:1516-28.
47. Birkett A, Muir J, Phillips J, Jones G, O'Dea K. Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr 1996;63:766-72.
48. Bliss DZ, Stein TP, Schleifer CR, Settle RG. Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet. Am J Clin Nutr 1996;63:392-8.
49. Younes H, Demigné C, Behr S, Rémésy C. Resistant starch exerts a lowering effect on plasma urea by enhancing urea N transfer into the large intestine. Nutr Res 1995;15:1199-210.
50. Kieffer DA, Piccolo BD, Vaziri ND, Liu S, Lau WL, Khazaeli M, Nazertehrani S, Moore ME, Marco ML, Martin RJ, et al. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am J Physiol Renal Physiol 2016;310:F857-71.
51. Vaziri ND, Liu SM, Lau WL, Khazaeli M, Nazertehrani S, Farzaneh SH, Kieffer DA, Adams SH, Martin RJ. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLoS One 2014;9:e114881.
52. Younes H, Alphonse J-C, Behr SR, Demigné C, Rémésy C. Role of fermentable carbohydrate supplements with a low-protein diet in the course of chronic renal failure: experimental bases. Am J Kidney Dis 1999;33:633-46.
53. Boler BM, Rossoni Serao MC, Bauer LL, Staeger MA, Boileau TW, Swanson KS, Fahey GC. Digestive physiological outcomes related to polydextrose and soluble maize fibre consumption by healthy adult men. Br J Nutr 2011;106:1864-71.
54. Mackenzie B, Erickson JD. Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch 2004;447:784-95.
55. Brosnan ME, Brosnan JT. Hepatic glutamate metabolism: a tale of 2 hepatocytes. Am J Clin Nutr 2009;90(Suppl):857S-61S.
56. Glue P, Clement RP. Cytochrome P450 enzymes and drug metabolism-basic concepts and methods of assessment. Cell Mol Neurobiol 1999;19:309-23.
57. Nemoto N, Sakurai J. Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes. Arch Biochem Biophys 1995;319:286-92.
58. Luo G, Zeldin DC, Blaisdell JA, Hodgson E, Goldstein JA. Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys 1998;357:45-57.
59. Wang H, Zhao Y, Bradbury JA, Graves JP, Foley J, Blaisdell JA, Goldstein JA, Zeldin DC. Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities. Mol Pharmacol 2004;65:1148-58.
60. Powell PK, Wolf I, Jin R, Lasker JM. Metabolism of arachidonic acid to 20-hydroxy-5, 8, 11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 1998;285:1327-36.
61. Campbell WB. New role for epoxyeicosatrienoic acids as antiinflammatory mediators. Trends Pharmacol Sci 2000;21:125-7.
62. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6:947-60.
63. Chaluvadi MR, Nyagode BA, Kinloch RD, Morgan ET. TLR4-dependent and-independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease. Biochem Pharmacol 2009;77:464-71.
64. Nyagode BA, Williams IR, Morgan ET. Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes. Inflammation 2014;37:893-907.
65. Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clin J Am Soc Nephrol 2014;9:1603-10.
66. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen T-H, Andersen GL. Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013;83:308-15.
67. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 2012;23:1258-70.